The VIP regimen effective treatment to refractory choriocarcinoma: a case report.
This is a case report of a female patient who tried another regimen after EMA-CO regimen failed. A 30-year-old female, gravida 4, para 2, abortus 2, blood grouping O (grouping B of her husband), was a victim of choriocarcinoma of the uterus and was resistant to multiple combination regimens of chemotherapy (EMA-CO, EMA-PE, BEP). She was finally cured by the VIP regimen of chemotherapy. The VIP regimen may be considered as an effective protocol to cure refractory choriocarcinoma.
Wang
P H
PH
Department of Obstetrics and Gynecology, Veterans General Hospital-Taipei, Taiwan, R.O.C.
Yuan
C C
CC
Chao
H T
HT
Wang
H M
HM
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002822:Choriocarcinoma / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D011247:Pregnancy; D014594:Uterine Neoplasms / Q000188:drug therapy*
D005047:Etoposide; D002945:Cisplatin; D007069:Ifosfamide